SeedRound Media
Rushed for time? Here is the top 5 Seed investors for Biotechnology startups. Scroll down for more information on these investors or to view the rest of the investors.
Name | Website | Stages | Location | Socials |
|---|---|---|---|---|
RebelBio | Early Stage Venture, Seed | London, England, United Kingdom, Europe | ||
Wellcome Trust | Early Stage Venture, Late Stage Venture, Private Equity, Seed | London, England, United Kingdom, Europe | ||
UK Innovation & Science Seed Fund | Early Stage Venture, Late Stage Venture, Seed | Harwell, Oxfordshire, United Kingdom, Europe | ||
GM&C Life Sciences Fund | Early Stage Venture, Seed | Alderley Edge, Cheshire, United Kingdom, Europe | ||
DigitalHealth.London Accelerator | Seed | London, England, United Kingdom, Europe |
At SeedRound we track over 200,000 investors and over 1,000,000 people who hold key positions in these firms. We use this directory of investors to highlight top employees, LP’s and funding organisations we think deserve more appreciation than they are currently getting.
We’ve ranked the top Biotechnology Seed investors in United Kingdom. The companies, startups and institutions listed in this article are all exceptional companies, well worth a follow. We have included links to their websites, socials and CrunchBase (if you’re interested in their financials).
We selected the organisations listed in this article based on:
- Track record
- Executive leadership
- Market share
- Innovation
- ESG rating
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Top Biotechnology Investors & Funds (United Kingdom)
RebelBio
RebelBio is the London based team of the venture capital firm SOSV. RebelBio specializes in pre-seed investments in BioTech, HealthTech & Life Sciences. It invests broadly in science-based, tech-enabled early stage startups. RebelBio backs 16 companies per year through its 3 months investment programme. During that time founders receive pre-seed funding and hands-on support from the VC team, working closely to de-risk and fast track the growth of their companies. After the programme, startups can get follow-on investment from RebelBio’s fund SOSV, and support to its founders over the following years.
Stages: Early Stage Venture, Seed
Location: London, England, United Kingdom, Europe
Industries: Biotechnology, Finance, Life Science, Venture Capital
Follow:
Wellcome Trust
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Stages: Early Stage Venture, Late Stage Venture, Private Equity, Seed
Location: London, England, United Kingdom, Europe
Industries: Biotechnology, Health Care, Medical, Non Profit
Follow:
UK Innovation & Science Seed Fund
The UK Innovation & Science Seed Fund is backed by the Department for Business, Energy and Industrial Strategy and the Fund’s partners are 9 publicly funded research bodies, including STFC, BBSRC, NERC and Dstl. The Fund is independently managed by venture capital specialist Midven. They help build companies from great science developed in laboratories, science and technology campuses and synthetic biology. They hold investments in some of the UK’s most innovative companies, in areas as diverse as novel antibiotics, research into Alzheimer’s disease, “green” chemicals and airport security.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Harwell, Oxfordshire, United Kingdom, Europe
Industries: Biotechnology, Financial Services, Venture Capital
Follow:
GM&C Life Sciences Fund
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers (“Catapult Ventures”). The Fund is based at Alderley Park, which is well recognised as a site of national importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca. Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Stages: Early Stage Venture, Seed
Location: Alderley Edge, Cheshire, United Kingdom, Europe
Industries: Biotechnology, Finance, Financial Services, Venture Capital
Follow:
Fusion IP
Fusion IP owns the rights to 100% of university-owned research generated at two of the UK’s leading universities – The University of Sheffield and Cardiff University. These exclusive partnerships enable us to develop some of the world’s most advanced and exciting science, in fields as varied as clean energy, electronics, engineering and medicine; turning world class research into valuable businesses through the creation of portfolio of companies.
Stages: Debt, Seed
Location: Sheffield, Sheffield, United Kingdom, Europe
Industries: Biotechnology, Education, Finance
Follow:
Deep Science Ventures
Deep Science Ventures is an accelerator that works with scientists to build companies, from scratch, across domains from biochemistry to nano-tech. They provide a basic salary to fund the first 3 months of the program, followed by a £30k investment into those teams that demonstrate the commercial and technical viability of their startup. It is based in London, United Kingdom.
Stages: Seed, Venture
Location: London, England, United Kingdom, Europe
Industries: Biopharma, Biotechnology, Commercial, Industrial Engineering, Life Science, Mechanical Engineering, Venture Capital
Follow:
Accelerate@Babraham
The aim of Accelerate@Babraham is to support the development of science concepts and the creation of new companies by providing access to equipped communal laboratories on short-term agreements, as well as guidance from mentors and introductions to investors. The concept complements the Babraham Research Campus’ ongoing support of the Cambridge life science cluster through the provision of access to the campus community and infrastructure without the need to be an established occupier on site.
Stages: Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Biopharma, Biotechnology, Life Science, Medical
Follow:
Synthesis Capital
Synthesis Capital is an investment manager transforming our food system through food technology.
Stages: Early Stage Venture, Late Stage Venture, Seed, Venture
Location: London, England, United Kingdom, Europe
Industries: Biotechnology, Food and Beverage
Follow:
Start Codon
Start Codon identifies the most disruptive and innovative life science start-ups worldwide, seed-funds them and leverages the exceptional resources of the Cambridge Cluster to de-risk and drive their success
Stages: Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Biotechnology, Health Care, Incubators, Life Science, Venture Capital
Follow:
Future Care Capital
In pursuance of its charitable mission, Future Care Capital (FCC) will use its resources to identify and support innovation through the launch of a dedicated Innovation Fund. The Innovation Fund aims to help address major healthcare needs, such as mental health, ageing and living with chronic medical conditions, by investing in innovative enterprises. It will also have an ethical investment policy that will drive its activities in compliance with the charity’s policies and aims. The Fund will invest in UK based, early-stage, high-tech, high-growth enterprises in the field of digital health (including machine learning and AI), assisted living, services and Class I medical devices.
Stages: Early Stage Venture, Seed, Venture
Location: London, England, United Kingdom, Europe
Industries: Biotechnology, Health Care, Life Science, Medical, Pharmaceutical
Follow:
